This Biopharmaceutical Stock Could Triple From Current Levels
The biopharmaceutical stock discussed in today’s article could triple from current levels if the positive thesis of one analyst covering the stock plays out –…
Bullish
These 3 Biotechs Have Different Approaches To A COVID-19 Vaccine, But The Same Analyst Rating: ‘Buy’
An intranasal vaccine, an mRNA vaccine, and a T-cell activation vaccine: the three biotech companies discussed in today’s article are approaching the virus that causes…
“Not Your Typical Fertilizer”: The Bullish Case For Potash
With the world’s population growing and the amount of food being consumed increasing, fertilizer will become more important than ever. This creates a profit-making opportunity…